|
|
|
Insider
Information: |
Almstead Neil Gregory |
Relationship: |
|
City: |
South Plainfield |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
86,202 |
|
Indirect Shares
|
4,576 |
|
|
Direct
Value |
$2,933,454 |
|
|
Indirect Value
|
$155,721 |
|
|
Total
Shares |
90,778 |
|
|
Total
Value |
$3,089,175 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
29
|
Stock
price went up :
|
0
|
12
|
Stock
price went down : |
0
|
17
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-418.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
PTC Therapeutics, Inc. |
PTCT |
|
2024-02-15 |
86,202 |
2024-02-15 |
4,576 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
78 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
PTCT |
PTC Therapeutics, Inc. |
Senior VP, Research and CMCOff |
|
2013-06-19 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,549 |
|
- |
|
PTCT |
PTC Therapeutics, Inc. |
Senior VP, Research and CMCOff |
|
2013-06-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
40,740 |
|
- |
|
PTCT |
PTC Therapeutics, Inc. |
Senior VP, Research and CMC |
|
2014-03-19 |
4 |
AS |
$31.90 |
$346,557 |
D/D |
(10,859) |
29,881 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
Senior VP, Research and CMC |
|
2014-12-04 |
4 |
AS |
$50.00 |
$8,750 |
I/I |
(175) |
1,374 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
EVP, Research and CMC |
|
2015-01-20 |
4 |
OE |
$10.85 |
$272,335 |
D/D |
25,100 |
54,981 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
EVP, Research and CMC |
|
2015-01-20 |
4 |
AS |
$60.25 |
$1,512,660 |
D/D |
(25,100) |
29,881 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
EVP, Research and CMC |
|
2015-01-21 |
4 |
AS |
$60.00 |
$59,760 |
D/D |
(996) |
29,881 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
EVP, Research and CMC |
|
2015-01-21 |
4 |
OE |
$10.85 |
$10,807 |
D/D |
996 |
30,877 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
EVP, Research and CMC |
|
2015-02-17 |
4 |
AS |
$53.37 |
$211,212 |
D/D |
(3,904) |
29,881 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
EVP, Research and CMC |
|
2015-02-17 |
4 |
OE |
$10.85 |
$42,358 |
D/D |
3,904 |
33,785 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
EVP, Research and CMC |
|
2015-03-10 |
4 |
AS |
$70.71 |
$5,586 |
I/I |
(79) |
1,295 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
EVP Research Pharma Ops & Tech |
|
2015-03-19 |
4 |
AS |
$69.36 |
$1,426,240 |
D/D |
(20,370) |
9,511 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
EVP Research Pharma Ops & Tech |
|
2015-04-15 |
4 |
AS |
$68.35 |
$652,913 |
D/D |
(9,511) |
0 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
EVP Research Pharma Ops & Tech |
|
2016-09-27 |
4 |
OE |
$10.85 |
$108,500 |
D/D |
10,000 |
10,000 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
EVP Research Pharma Ops & Tech |
|
2017-01-03 |
4 |
A |
$0.00 |
$0 |
I/I |
720 |
2,765 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
EVP Research Pharma Ops & Tech |
|
2017-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
16,000 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
EVP Research Pharma Ops & Tech |
|
2017-01-05 |
4 |
S |
$11.82 |
$922 |
I/I |
(78) |
2,687 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
EVP Research Pharma Ops & Tech |
|
2018-01-03 |
4 |
A |
$0.00 |
$0 |
I/I |
874 |
5,284 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
EVP Research Pharma Ops & Tech |
|
2018-01-04 |
4 |
S |
$17.67 |
$1,361 |
I/I |
(77) |
5,207 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
EVP Research Pharma Ops & Tech |
|
2018-01-05 |
4 |
S |
$18.03 |
$1,478 |
I/I |
(82) |
5,125 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
EVP Research Pharma Ops & Tech |
|
2018-01-05 |
4 |
S |
$18.03 |
$11,197 |
D/D |
(621) |
17,154 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
EVP Research Pharma Ops & Tech |
|
2018-06-19 |
4 |
AS |
$48.09 |
$966,240 |
D/D |
(20,000) |
17,154 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
EVP Research Pharma Ops & Tech |
|
2018-06-19 |
4 |
OE |
$10.85 |
$217,000 |
D/D |
20,000 |
37,154 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
Chief Technical Ops Officer |
|
2019-01-07 |
4 |
S |
$34.75 |
$6,255 |
I/I |
(180) |
5,649 |
0 |
- |
|
PTCT |
PTC Therapeutics, Inc. |
Chief Technical Ops Officer |
|
2019-01-07 |
4 |
S |
$34.75 |
$16,437 |
D/D |
(473) |
17,396 |
0 |
- |
|
78 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|